The purpose of the Mary Kay Ash Foundation Innovative/Translational Cancer Research Award is to fund research in ovarian, uterine, breast, or cervical cancer. Translational research is broadly defined as research that will provide a scientific link between laboratory research and the clinic. Ultimately, the Foundation hopes that such research will lead to improvement in diagnosis, prognosis, prevention, or treatment of cancer. The Foundation anticipates funding between ten and fifteen grants. Internal deadline: December 19, 2014 … Read More
Posts Tagged ‘translational research’
The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for its Biomedical Innovation Program. The program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software with the objective of moving innovative technologies to clinical application, making a meaningful impact on human health. Deadline: Letters of intent due Nov. 12, 2014 Amount: Up to $40,000 over one year Eligibility: Principal investigators must fit OHSU eligibility … Read More
Did you know that the NIH Common Fund was holding a video competition to commemorate its 10-year anniversary? Neither did we, but after seeing this Common Fund rap, we will definitely be going with the Common Fund.
OCTRI Research Forum: Need Patient Data? Using the OHSU Research Data Warehouse and Oregon’s All Payers, All Claims database. Oct, 20.
Join the Oregon Clinical and Translational Research Institute, OCTRI, in a monthly research forum that addresses all things clinical and translational research. Topics will be presented in a problem – solution fashion and anyone from the research arena is welcome! Do you have a clinical or translational research question or problem? Let us know and we’ll do our best to help during these events! Please submit questions and topic requests to Colleen Berreta. Don’t miss … Read More
You may have read that a drug from an OHSU startup received FDA approval last month. In 2003, OHSU’s office of Technology Transfer & Business Development (TTBD) created a start-up company called Orexigen Therapeutics, Inc., with Michael Cowley, then a neuroscience researcher at the Oregon National Primate Research Center. Cowley’s work looks at the appetite-regulating pathways in the brain and how these pathways are affected by obesity. Orexigen Therapeutics became public in 2007, and now the … Read More
James D. Ross, Ph.D., DAF: Aortic Occlusion Systems: Potentially Powerful Tools, Significant Risk? – 9/25
James D. Ross, Ph.D., DAF, Air Force Medical Service and Director of the Air Force Trauma and Resuscitation Research Program, Joint Base San Antonio – Lackland, will present his talk, “Aortic Occlusion Systems: Potentially Powerful Tools, Significant Risk?” on Thursday, Sept 25th, 4 p.m., Mackenzie Hall 3198. Dr. Ross is a translational science expert in trauma and hemorrhage. He joined the Naval Medical Research Unit, San Antonio in 2010 as a Senior Research Physiologist for … Read More
Research Scholar Grants are intended to provide support for investigator-initiated projects across the cancer research continuum. These grants provide up to $165,000 per year for up to four years and typically cover the costs of salaries, consumable supplies, and other miscellaneous items required to conduct the proposed research. This funding mechanism supports basic, preclinical, clinical, epidemiological, psychosocial, behavioral research, and research in palliative care and symptom management. Independent investigators within the first six years of … Read More
The American Society of Hematology will honor Grover C. Bagby Jr., M.D., with a 2014 Mentor Award at the 56th Annual ASH Meeting and Exposition in San Francisco for his sustained, outstanding commitment to the training and career development of early-career hematologists. Dr. Bagby, professor of medicine and molecular and medical genetics in the OHSU School of Medicine, and founding director of the OHSU Knight Cancer Institute, will be presented with the award for his … Read More
The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of four research awards through its Biomedical Innovation Program. The Program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software. Via commercialization from academia to the marketplace, the objective is to move innovative technologies to clinical application, and thus to make a meaningful impact on human health. The Biomedical Innovation Program is a collaboration between OCTRI and OHSU … Read More
The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting applications for Pilot Funding for Development of Novel Research Methodologies. The intent of this funding mechanism is to encourage and accelerate the creation, dissemination, and implementation of novel translational and clinical research methodologies. The development of new methodologies is critical to the advancement of translational and clinical research. OHSU investigators have often been actively involved in creating translational research methods, and this program provides … Read More